HUTCHMED (China) (HCM) Invested Capital (2015 - 2025)
HUTCHMED (China)'s (HCM) quarterly Invested Capital came in at $12.0 million in Q4 2025, up 12.46% year-on-year from $10.7 million in Q4 2024, and down 53.22% on a QoQ basis from $25.6 million in Q2 2025.
HUTCHMED (China) (HCM) Invested Capital (2015 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 11 years of Invested Capital data on file, last reported at $12.0 million in Q4 2025.
- On a quarterly basis, Invested Capital rose 12.46% year-over-year to $12.0 million in Q4 2025; TTM through Dec 2025 was $74.7 million, a 99.27% decrease from a year earlier, with the FY2025 full-year figure at $12.0 million, up 12.87% from the prior year.
- Invested Capital for Q4 2025 stood at $12.0 million, down from $25.6 million in the prior quarter.
- Over the last five years, Invested Capital for HCM reached as high as $10.2 billion in Q4 2023 and fell as low as $418000.0 in Q2 2022.
- Historically, Invested Capital has averaged $1.1 billion across 5 years, with a median of $12.0 million in 2025.
- Across the five-year window, Invested Capital soared 438655.81% in 2023 and slumped 99.9% in 2024, its largest moves.
- Year by year, Invested Capital stood at $3.5 million in 2021, then slumped by 32.99% to $2.3 million in 2022, then surged by 438655.81% to $10.2 billion in 2023, then slumped by 99.9% to $10.7 million in 2024, then climbed by 12.46% to $12.0 million in 2025.
- Per Business Quant data, the three most recent Invested Capital figures were $12.0 million in Q4 2025, $25.6 million in Q2 2025, and $10.7 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 31.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.93 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 73.00 Mn |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - | 11.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.98 Mn |
| Jun 30, 2025 | 25.60 Mn |
| Dec 31, 2024 | 10.65 Mn |
| Jun 30, 2024 | 26.47 Mn |
| Dec 31, 2023 | 10.15 Bn |
| Dec 31, 2022 | 2.31 Mn |
| Jun 30, 2022 | 418,000.00 |
| Dec 31, 2021 | 3.45 Mn |
| Jun 30, 2021 | 26.88 Mn |
| Dec 31, 2020 | 401,000.00 |
| Dec 31, 2019 | 366,000.00 |
| Dec 31, 2018 | 432,000.00 |
| Jun 30, 2018 | 10.69 Mn |
| Dec 31, 2017 | 29.99 Mn |
| Jun 30, 2017 | 26.86 Mn |
| Dec 31, 2016 | 19.96 Mn |
| Jun 30, 2016 | 15.08 Mn |
| Dec 31, 2015 | 23.08 Mn |